key: cord-0703680-x44iwk4w
authors: Horvath, Angela; Lind, Theresa; Frece, Natalie; Wurzer, Herbert; Stadlbauer, Vanessa
title: Risk stratification in hospitalized COVID-19 patients
date: 2021-04-24
journal: J Hepatol
DOI: 10.1016/j.jhep.2021.04.024
sha: be71c0b7456f1bdcb4f7f01b88877213bc37276d
doc_id: 703680
cord_uid: x44iwk4w

nan

Conflict of interest: The authors declare no conflict of interest.

Financial support: No financial support was given in order to complete the study or write the manuscript Authors contribution: TL, NF, HW collected data, AH, VS analysed the data and wrote the manuscript Ding et al. recently published a retrospective analysis of potential predictors for mortality of 2073 hospitalized Chinese COVID-19 patients. [1] As their main findings, they reported that increased liver parameters as well as liver injury were predictive for 28-day mortality, and proposed a nomogram that estimates the mortality risk of J o u r n a l P r e -p r o o f hospitalized patients with COVID-19 disease. However, as the understanding of COVID-19 disease improves, it becomes evident that the disease may present differently in different regions. Liver injury, as well as other gastrointestinal symptoms were associated with worse outcome in some, but not all studies. [2] [3] [4] [5] [6] [7] Therefore, we set out to validate the main findings in an Austrian cohort of 405 hospitalized patients with COVID-19 disease.

We retrospectively collected demographic and laboratory data as well as in-hospital mortality from all patients with a positive SARS-Cov-2 PCR test hospitalized at either the University Hospital Graz or the State Hospital Graz II between February 28 th , 2020 and May 30 th , 2020. Due to availability, the nomogram parameters direct bilirubin and troponin I were substituted with total bilirubin and troponin T, respectively. Cox-Regression was used to estimate hazard ratios for 7-, 14-, 21-and 28-day in-hospital mortality; p-values below 0.05 was considered significant. Monte-Carlo simulation were run to define cut-offs with the highest overall accuracy. Although the proposed nomogram is performing well, it is rather complicated to calculate which could be a considerable disadvantage in well-frequented COVID-19 wards. We propose a simplified version based on the predictors that we could reliably reproduce in the Austrian cohort. The simplified score is composed of the sum of the following: age decade, 4 points for severe pneumonia, 8 points for C-reactive protein over 10mg/L, 4 points for creatinine over 84µmol/L. This simplified version can still predict 28-day mortality (HR=1.24, 95%CI: 1.16,1.34; p<0.001) and shows comparable accuracy to the full version of the nomogram (AUC-difference: -0.001; 95%CI: -0.05,0.05; p=0.9). A score of 22 or higher best identified patients at risk for 28-day in-hospital mortality (figure 1).

In conclusion, we validated and simplified the nomogram proposed by Ding et al. [1] although liver injury itself was not predictive in our cohort. The divergence in liver J o u r n a l P r e -p r o o f function-related findings is not unexpected. Several meta-analyses in the past six months showed that a certain fraction of individual studies indicated no association between liver function abnormalities and outcome, although, overall, they were associated with disease severity and outcome. [3, 5, 6] Our retrospective study design is not suited to address the source of this discrepancy. However, direct comparison of the two study populations showed that patients in our cohort were 74 (±14) years old and therefore 12 year older on average compared to Ding et al., which might explain the considerably higher mortality rate as well as the higher prevalence of liver function abnormalities (74% vs 61%, respectively) in our cohort. 

Association of liver abnormalities with inhospital mortality in patients with COVID-19

The liver injury and gastrointestinal symptoms in patients with Coronavirus Disease 19: A systematic review and meta-analysis

Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19

Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis

A meta-analysis of the impact of COVID-19 on liver dysfunction

Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis

Patients With Gastrointestinal Symptoms: A Systematic Review and Meta-analysis